VIDUS OCULAR
Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. It offers Aquashunt, which is a shunt to treat glaucoma, the cause of blindness in the United States. The company is based in the United States. As of May 7, 2008, Vidus Ocular, Inc. operates as a subsidiary of Opko Health, Inc.
Similar Organizations
Capillect
Capillect develops a minimally invasive blood collection device to be implemented in the current blood sampling workflows.
Current Employees Featured
Bruce Shields
Bruce Shields Chief Scientific & Medical Officer @ Vidus Ocular Chief Scientific & Medical Officer
Ben R. Bronstein
Ben R. Bronstein President and COO @ Vidus Ocular President and COO